REBLOZYL® (luspatercept-aamt) logo
Now approved for earlier treatment of MDS-related anemia badge

INDICATIONS (1 of 3)

REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions.

It is not known if REBLOZYL is safe or effective in children under 18 years of age.

Now approved for earlier treatment of MDS-related anemia badge

This website is best viewed using the horizontal display on your tablet device.

This website is best viewed using the vertical display on your mobile device.

Sign up below and
you’ll receive ongoing
support and resources
throughout your
treatment journey.

Your REBLOZYL Connection is an educational program designed to help you understand your treatment with REBLOZYL, and provide resources that allow you to be more active with your care.

Thank you for signing up. [You’ll be receiving your Welcome Kit in the mail soon.] Look out for future communications in your inbox.